3//SEC Filing
Growth Equity Opportunities V, LLC 3
Accession 0001209191-17-046771
CIK 0001505512other
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 5:55 PM ET
Size
9.2 KB
Accession
0001209191-17-046771
Insider Transaction Report
Form 3
Growth Equity Opportunities V, LLC
10% Owner
Holdings
- 10,989,010
Common Stock
New Enterprise Associates 16, L.P.
10% Owner
Holdings
- 10,989,010
Common Stock
NEA Partners 16, L.P.
10% Owner
Holdings
- 10,989,010
Common Stock
NEA 16 GP, LLC
10% Owner
Holdings
- 10,989,010
Common Stock
Footnotes (2)
- [F1]The shares are directly held by Growth Equity Opportunities Fund V, LLC ("GEO V") and indirectly held by New Enterprise Associates 16, L.P. ("NEA 16"), the sole member of GEO V, NEA Partners 16, L.P. ("NEA Partners"), the sole general partner of NEA 16, NEA 16 GP, LLC ("NEA 16 GP"), the sole general partner of NEA Partners 16, and the individual managers of NEA 16 GP (NEA 16, NEA Partners 16, NEA 16 GP and the individual managers of NEA 16 GP, together, the "Indirect Reporting Persons").
- [F2]The individual managers of NEA 16 GP are Peter J. Barris, Forest Baskett, Anthony A. Florence, Jr., Mohamad Makhzoumi, Josh Makower, David M. Mott, Chertan Puttagunta, Jon Sakoda, Scott D. Sandell, Peter W. Sonsini and Ravi Viswanathan. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares of the Issuer held by GEO V in which the Indirect Reporting Persons have no pecuniary interest.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001706444
Filing Metadata
- Form type
- 3
- Filed
- Jul 30, 8:00 PM ET
- Accepted
- Jul 31, 5:55 PM ET
- Size
- 9.2 KB